Abstract
Thirty patients with symptoms of duodenal ulceration were treated for five to eight weeks in a double-blind trial with either metiamide 1 g daily by mouth or a placebo. In the 15 patients receiving metiamide there were significant reductions in nocturnal pain and antacid consumption. Daytime pain was diminished. The results suggest that histamine H2-receptor antagonists are likely to be useful in the medical management of the symptoms of duodenal ulceration.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carter D. C., Forrest J. A., Werner M., Heading R. C., Park J., Shearman D. J. Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J. 1974 Aug 31;3(5930):554–556. doi: 10.1136/bmj.3.5930.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konturek S. J., Biernat J., Oleksy J. Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis. 1974 Jul;19(7):609–616. doi: 10.1007/BF01073015. [DOI] [PubMed] [Google Scholar]
- Mainardi M., Maxwell V., Sturdevant R. A., Isenberg J. I. Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer. N Engl J Med. 1974 Aug 22;291(8):373–376. doi: 10.1056/NEJM197408222910801. [DOI] [PubMed] [Google Scholar]
- Milton-Thompson G. J., Williams J. G., Jenkins D. J., Misiewicz J. J. Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide. Lancet. 1974 Apr 20;1(7860):693–694. doi: 10.1016/s0140-6736(74)92901-8. [DOI] [PubMed] [Google Scholar]
- Thjodleifsson B., Wormsley K. G. Gastric response to metiamide. Br Med J. 1974 May 11;2(5914):304–306. doi: 10.1136/bmj.2.5914.304. [DOI] [PMC free article] [PubMed] [Google Scholar]